Exercise Is Medicine for Nonalcoholic Fatty Liver Disease: Exploration of Putative Mechanisms
Open accessThe DOI matches its Crossref record; 155 of the 156 references it cites were found in a registry or an index.
Abstract
Exercise remains a key component of nonalcoholic fatty liver disease (NAFLD) treatment. The mechanisms that underpin improvements in NAFLD remain the focus of much exploration in our attempt to better understand how exercise benefits patients with NAFLD. In this review, we summarize the available scientific literature in terms of mechanistic studies which explore the role of exercise training in modulating fatty acid metabolism, reducing hepatic inflammation, and improving liver fibrosis. This review highlights that beyond simple energy expenditure, the activation of key receptors and pathways may influence the degree of NAFLD-related improvements with some pathways being sensitive to exercise type, intensity, and volume. Importantly, each therapeutic target of exercise training in this review is also the focus of previous or ongoing drug development studies in patients with nonalcoholic steatohepatitis (NASH), and even when a regulatory-agency-approved drug comes to market, exercise will likely remain an integral component in the clinical management of patients with NAFLD and NASH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Aerobic exercise improves key pathophysiologic mechanisms in MASH by enhancing insulin sensitivity, reducing hepatic fat accumulation, increasing mitochondrial fatty acid oxidation, and modulating pro- and anti-inflammatory cytokines independent of weight loss [33].”
From Aerobic Exercise Training Leads to MASH Resolution as Defined by the MASH Resolution Index (2026) · cites this paper as [33]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Hepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver
Berglund, E. D., Lustig, D. G., Baheza, R. A., Hasenour, C. M., Lee-Young, R. S., Donahue, E. P., Lynes, S. E., Swift, L. L., Charron, M. J., Damon, B. M., et al. (2011) · Diabetes · doi:10.2337/db11-0455 · Cited by 44 · cited 1×
“PPAR-γ is heavily involved in glucagon signaling and insulin sensitivity and, thus, is closely related to adiposity-related disorders [94,95].”
BackgroundRetractedCintra, D. E., Ropelle, E. R., Vitto, M. F., Luciano, T. F., Souza, D. R., Engelmann, J., Marques, S. D. O., Lira, F. S., Pinho, R. A., Pauli, J. R., et al. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.08.002 · Cited by 35
Retracted(1985) · Europe PMC (PubMed Central) · Cited by 9,143
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2032183 · Cited by 5,205 · cited 1×
“GLP-1 has recently emerged at the forefront of drug development in NASH given the recent promising results of early-phase studies using both semaglutide [11] as well as liraglutide [53] and the fact that several GLP-1 receptor agonists are regulatory-agency-approved for the medical treatment of overweight and obesity…”
BackgroundOxidative Stress: Harms and Benefits for Human Health
Pizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V., Squadrito, F., Altavilla, D., & Bitto, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8416763 · Cited by 4,837
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639 · cited 1×
“One such hormone is GLP-1, an incretin, which helps to regulate satiety and lipid metabolism in both the fasting and glucose-stimulated states [52].”
BackgroundYounossi, Z. M., Golabi, P., Paik, J. M., Henry, A., Van Dongen, C., & Henry, L. (2023) · Hepatology · doi:10.1097/hep.0000000000000004 · Cited by 3,383 · cited 1×
“Upwards of 30% of the world’s population has nonalcoholic fatty liver disease (NAFLD) [1].”
BackgroundPioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327 · cited 2×
“The PPAR pathway remains one of many targets for drug discovery of anti-steatogenic medications, where late-phase studies have demonstrated PPAR-γ agonists, such as pioglitazone [96], and dual PPAR-α/γ agonists, such as saroglitazar [15], improve insulin resistance and lipid metabolism through regulation of fatty acid…”
BackgroundRinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667 · cited 1×
“However, most patients with NAFLD do not meet recommended amounts of weekly physical activity [2], and no one optimal diet has been established, although a Mediterranean-informed diet appears to hold the most promise and is recommended by several leading gastroenterology and hepatology societies [3,4].”
BackgroundArmstrong, M. J., Gaunt, P., Aithal, G. P., Barton, D., Hull, D., Parker, R., Hazlehurst, J. M., Guo, K., Abouda, G., Aldersley, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00803-x · Cited by 2,203 · cited 1×
“GLP-1 has recently emerged at the forefront of drug development in NASH given the recent promising results of early-phase studies using both semaglutide [11] as well as liraglutide [53] and the fact that several GLP-1 receptor agonists are regulatory-agency-approved for the medical treatment of overweight and obesity…”
BackgroundThe gut-liver axis in liver disease: Pathophysiological basis for therapy
Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166
A Placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis
Newsome, P. N., Buchholtz, K., Cusi, K., Linder, M., Okanoue, T., Ratziu, V., Sanyal, A. J., Sejling, A.-S., & Harrison, S. A. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2028395 · Cited by 2,039 · cited 2×
“GLP-1 has recently emerged at the forefront of drug development in NASH given the recent promising results of early-phase studies using both semaglutide [11] as well as liraglutide [53] and the fact that several GLP-1 receptor agonists are regulatory-agency-approved for the medical treatment of overweight and obesity…”
BackgroundMolecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function
Hardie, D. G. (2011) · Genes & Development · doi:10.1101/gad.17420111 · Cited by 1,638 · cited 1×
“As exercise intensity and duration increase, ATP usage increases to the point where it cannot be regenerated quickly enough, increasing the AMP/ADP:ATP ratio and activating AMPK [25].”
BackgroundBile acids and the gut microbiota: metabolic interactions and impacts on disease
Collins, S. L., Stine, J. G., Bisanz, J. E., Okafor, C. D., & Patterson, A. D. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00805-x · Cited by 1,214
Self-citationMitochondrial superoxide: production, biological effects, and activation of uncoupling proteins
Brand, M. D., Affourtit, C., Esteves, T. C., Green, K., Lambert, A. J., Miwa, S., Pakay, J. L., & Parker, N. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.05.034 · Cited by 1,032
Tyagi, S., Gupta, P., Saini, A., Kaushal, C., & Sharma, S. (2011) · Journal of Advanced Pharmaceutical Technology & Research · doi:10.4103/2231-4040.90879 · Cited by 1,017 · cited 1×
“The receptor can be found in many key organs, including the liver, and has three subtypes, PPAR-α, PPAR-γ and PPARβ/δ [91].”
BackgroundTriglyceride Metabolism in the Liver
Alves‐Bezerra, M., & Cohen, D. E. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170012 · Cited by 1,016
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Rolo, A. P., Teodoro, J. S., & Palmeira, C. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.003 · Cited by 955
Harrison, S. A., Bashir, M. R., Guy, C. D., Zhou, R., Moylan, C. A., Frias, J. P., Alkhouri, N., Bansal, M. B., Baum, S., Neuschwander-Tetri, B. A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32517-6 · Cited by 802 · cited 4×
“emerging therapy in NASH clinical trials that has the potential to significantly reduce hepatic fat, making it a potential therapy for patients with NASH [14].”
BackgroundInfluentialPhysiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3
Brand, M. D., & Esteves, T. C. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.002 · Cited by 785
Kurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., & Kuro-o, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704165200 · Cited by 748 · cited 1×
“Multiple isoforms of FGF are involved in the cascade, but FGF-19 and FGF-21 are closely related to fat metabolism [34] and are the signaling pathways for both hormones involved in NAFLD and NASH development and the focus of drug discovery [12,35].”
BackgroundFibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration
Yun, Y.-R., Won, J. E., Jeon, E., Lee, S., Kang, W., Jo, H., Jang, J.-H., Shin, U. S., & Kim, H.-W. (2010) · Journal of Tissue Engineering · doi:10.4061/2010/218142 · Cited by 712 · cited 1×
“FGF is a complex family of peptide hormones that has a crucial implication on regulating energy homeostasis and metabolism [33].”
BackgroundMouries, J., Brescia, P., Silvestri, A., Spadoni, I., Sorribas, M., Wiest, R., Mileti, E., Galbiati, M., Invernizzi, P., Adorini, L., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.005 · Cited by 688
Direct effects of thyroid hormones on hepatic lipid metabolism
Sinha, R. A., Singh, B. K., & Yen, P. M. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.10 · Cited by 660
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
Masarone, M., Rosato, V., Dallio, M., Gravina, A. G., Aglitti, A., Loguercio, C., Federico, A., & Persico, M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9547613 · Cited by 648
Loomba, R., Lawitz, E., Mantry, P. S., Jayakumar, S., Caldwell, S. H., Arnold, H., Diehl, A. M., Djedjos, C. S., Han, L., Myers, R. P., et al. (2018) · Hepatology · doi:10.1002/hep.29514 · Cited by 549
PPARs: Fatty acid sensors controlling metabolism
Poulsen, L. L. C., Siersbæk, M., & Mandrup, S. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.01.003 · Cited by 510 · cited 1×
“When expressed in the liver, PPAR-α is responsible for fatty acid catabolism and energy homeostasis [92,93].”
BackgroundTreatment of nonalcoholic fatty liver disease: role of AMPK
Smith, B. K., Marcinko, K., Desjardins, E. M., Lally, J. S., Ford, R. J., & Steinberg, G. R. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00225.2016 · Cited by 500 · cited 1×
“AMPK activity is abnormally low in patients with NAFLD, leading to excessive accumulation of liver fat [19].”
BackgroundHarrison, S. A., Wong, V. W.-S., Okanoue, T., Bzowej, N., Vuppalanchi, R., Younes, Z., Kohli, A., Sarin, S., Caldwell, S. H., Alkhouri, N., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.027 · Cited by 497
Younossi, Z. M., Corey, K. E., & Lim, J. K. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.11.051 · Cited by 490 · cited 1×
“However, most patients with NAFLD do not meet recommended amounts of weekly physical activity [2], and no one optimal diet has been established, although a Mediterranean-informed diet appears to hold the most promise and is recommended by several leading gastroenterology and hepatology societies [3,4].”
BackgroundAMPK and the biochemistry of exercise: implications for human health and disease
Richter, E. A., & Ruderman, N. B. (2009) · Biochemical Journal · doi:10.1042/bj20082055 · Cited by 481 · cited 2×
“Further, in order to generate additional ATP during exercise, glycogen, which is the main energy substrate used during exercise at higher intensities (typically greater than 70% of VO2max), dissociates from AMPK, leading to AMPK activation (glycogen-bound AMPK is inactive) [18,26,27].”
Background2,4-Dinitrophenol (DNP): A Weight Loss Agent with Significant Acute Toxicity and Risk of Death
Grundlingh, J., Dargan, P. I., El-Zanfaly, M., & Wood, D. M. (2011) · Journal of Medical Toxicology · doi:10.1007/s13181-011-0162-6 · Cited by 470 · cited 1×
“However, when medications with this mechanism of action have been used to induce body weight loss, they have been significantly limited by a strong side effect profile, and this target must be approached with caution [82].”
BackgroundTakaki, A., Kawai, D., & Yamamoto, K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141020704 · Cited by 447
Obesity Induces Expression of Uncoupling Protein-2 in Hepatocytes and Promotes Liver ATP Depletion
Chavin, K. D., Yang, S., Lin, H. Z., Chatham, J., Chacko, V. P., Hoek, J. B., Walajtys-Rode, E., Rashid, A., Chen, C.-H., Huang, C.-C., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5692 · Cited by 441 · cited 1×
“The dysfunction of these transporters has been correlated with various metabolic disorders, such as obesity and diabetes [76,77], and also NAFLD [78,79].”
BackgroundThe role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
Sun, L., Cai, J., & Gonzalez, F. J. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00404-2 · Cited by 435
The Role of Skeletal Muscle Glycogen Breakdown for Regulation of Insulin Sensitivity by Exercise
Jensen, J., Rustad, P. I., Kolnes, A. J., & Lai, Y.-C. (2011) · Frontiers in Physiology · doi:10.3389/fphys.2011.00112 · Cited by 412
Mitochondrial uncoupling proteins: from mitochondria to the regulation of energy balance
Ricquier, D., & Bouillaud, F. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00003.x · Cited by 385
Farzanegi, P., Dana, A., Ebrahimpoor, Z., Asadi, M., & Azarbayjani, M. A. (2019) · European Journal of Sport Science · doi:10.1080/17461391.2019.1571114 · Cited by 379
Gawrieh, S., Noureddin, M., Loo, N., Mohseni, R., Awasty, V., Cusi, K., Kowdley, K. V., Lai, M., Schiff, E., Parmar, D., et al. (2021) · Hepatology · doi:10.1002/hep.31843 · Cited by 379 · cited 2×
“The PPAR pathway remains one of many targets for drug discovery of anti-steatogenic medications, where late-phase studies have demonstrated PPAR-γ agonists, such as pioglitazone [96], and dual PPAR-α/γ agonists, such as saroglitazar [15], improve insulin resistance and lipid metabolism through regulation of fatty acid…”
BackgroundRoles of diacylglycerols and ceramides in hepatic insulin resistance
Petersen, M. C., & Shulman, G. I. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.004 · Cited by 373 · cited 1×
“While intrahepatic triglycerides themselves do not cause hepatic insulin resistance, it is thought that the accumulation of the aforementioned by-products impairs insulin receptor signaling through various mechanisms and has been identified as critical in the pathogenesis of hepatic insulin resistance [63].”
BackgroundAn Intestinal Microbiota–Farnesoid X Receptor Axis Modulates Metabolic Disease
Gonzalez, F. J., Jiang, C., & Patterson, A. D. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.057 · Cited by 372
Effect of Exercise Intensity on Skeletal Muscle AMPK Signaling in Humans
Chen, Z.-P., Stephens, T. J., Murthy, S., Canny, B. J., Hargreaves, M., Witters, L. A., Kemp, B. E., & McConell, G. K. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2205 · Cited by 369 · cited 1×
“Further, in order to generate additional ATP during exercise, glycogen, which is the main energy substrate used during exercise at higher intensities (typically greater than 70% of VO2max), dissociates from AMPK, leading to AMPK activation (glycogen-bound AMPK is inactive) [18,26,27].”
BackgroundHarrison, S. A., Ruane, P. J., Freilich, B. L., Neff, G., Patil, R., Behling, C. A., Hu, C., Fong, E., de Temple, B., Tillman, E. J., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01425-3 · Cited by 368 · cited 2×
“Both the FALCON and BALANCED trials investigated the efficacy of FGF-21 analogues pegbelfermin and efruxifermin in patients with NASH [13,35,36].”
BackgroundPatel, K., Harrison, S. A., Elkhashab, M., Trotter, J. F., Herring, R., Rojter, S. E., Kayali, Z., Wong, V. W., Greenbloom, S., Jayakumar, S., et al. (2020) · Hepatology · doi:10.1002/hep.31205 · Cited by 347 · cited 2×
“Newer-generation FXR agonists continue to be developed in the hopes of avoiding these limiting side effects while preserving efficacy, including tropifexor [9] and cilofexor [10], for which early-phase studies are quite promising.”
BackgroundSuzuki, M., Uehara, Y., Motomura-Matsuzaka, K., Oki, J., Koyama, Y., Kimura, M., Asada, M., Komi-Kuramochi, A., Oka, S., & Toru, T. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0313 · Cited by 345 · cited 1×
“Importantly, FGF-21 relies heavily on the coreceptor β-klotho [39].”
BackgroundChalasani, N., Deeg, M. A., & Crabb, D. W. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30159.x · Cited by 343
Sultana, R. N., Sabag, A., Keating, S. E., & Johnson, N. A. (2019) · Sports Medicine · doi:10.1007/s40279-019-01167-w · Cited by 286 · cited 1×
“As cardiorespiratory fitness has been shown to improve to a similar degree with both high-intensity interval training (HIIT) and more traditional moderate-intensity continuous training [69], this may, in part, explain why HIIT leads to similar improvements in hepatic steatosis to more moderate-intensity continuous exe…”
BackgroundSelf-citationLiver-specific Activities of FGF19 Require Klotho beta
Lin, B. C., Wang, M., Blackmore, C., & Desnoyers, L. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704244200 · Cited by 283 · cited 1×
“FGF-19 appears to largely act locally on the hepatocytes, whereas FGF-21 tends to be expressed systemically and, of particular interest, in the skeletal muscle, adipose tissue and in the liver tissue [37,38].”
BackgroundInterplay Between Exercise and Gut Microbiome in the Context of Human Health and Performance
Clauss, M., Gérard, P., Mosca, A., & Leclerc, M. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.637010 · Cited by 280
Nrf2: A Potential Target for New Therapeutics in Liver Disease
Bataille, A. M., & Manautou, J. E. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.110 · Cited by 229
Nedergaard, J., & Cannon, B. (2003) · Experimental Physiology · doi:10.1113/eph8802502 · Cited by 226
The mitochondrial uncoupling proteins.
Ledesma, A., de Lacoba, M. G., & Rial, E. (2002) · Genome biology · doi:10.1186/gb-2002-3-12-reviews3015 · Cited by 219 · cited 1×
“UCPs are a key component of mitochondrial metabolism and are mitochondrial inner-membrane proteins which mediate proton leak across the inner membrane through anion transport and uncouple substrate oxidation from ATP synthesis [71].”
BackgroundDalgaard, L. T., & Pedersen, O. (2001) · Diabetologia · doi:10.1007/s001250100596 · Cited by 217 · cited 1×
“The dysfunction of these transporters has been correlated with various metabolic disorders, such as obesity and diabetes [76,77], and also NAFLD [78,79].”
BackgroundExercise intensity and its effects on thyroid hormones.
Çiloğlu, F., Peker, İ., Pehlivan, A., Karacabey, K., İlhan, N., Saygın, Ö., & Özmerdivenli, R. (2005) · PubMed · Cited by 213
Vernia, S., Cavanagh-Kyros, J., Garcia-Haro, L., Sabio, G., Barrett, T., Jung, D. Y., Kim, J. K., Xu, J., Shulha, H. P., Garber, M., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.06.010 · Cited by 199
Vilar‐Gomez, E., Vuppalanchi, R., Gawrieh, S., Ghabril, M., Saxena, R., Cummings, O. W., & Chalasani, N. (2020) · Hepatology · doi:10.1002/hep.30368 · Cited by 193
Thyroid hormone signaling and the liver
Ritter, M. J., Amano, I., Hollenberg, A. N., et al. (2020) · Hepatology · doi:10.1002/hep.31296 · Cited by 188
Ohtani, N., & Kawada, N. (2019) · Hepatology Communications · doi:10.1002/hep4.1331 · Cited by 187
Ueda, S.-Y., Yoshikawa, T., Katsura, Y., Usui, T., & Fujimoto, S. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0190 · Cited by 178 · cited 1×
“Exercise can impact serum levels of GLP-1, and in fact, exercise can increase GLP-1 levels in healthy individuals and in persons with obesity and suppress appetite [56,57].”
BackgroundSanyal, A. J., Lopez, P., Lawitz, E. J., Lucas, K. J., Loeffler, J., Kim, W., Goh, G. B. B., Huang, J.-F., Serra, C., Andreone, P., et al. (2023) · Nature Medicine · doi:10.1038/s41591-022-02200-8 · Cited by 177 · cited 2×
“Newer-generation FXR agonists continue to be developed in the hopes of avoiding these limiting side effects while preserving efficacy, including tropifexor [9] and cilofexor [10], for which early-phase studies are quite promising.”
BackgroundUCP-3 expression in skeletal muscle: effects of exercise, hypoxia, and AMP-activated protein kinase
Zhou, M., Lin, B.-Z., Coughlin, S., Vallega, G., & Pilch, P. F. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.3.e622 · Cited by 166 · cited 1×
“Animal models have also demonstrated that UCP-2 is modulated by exercise in the vascular endothelium, myocardium, adipose tissue and skeletal muscle [84,88], as is UCP-3 in skeletal muscle [89].”
BackgroundDysfunctional Nrf2–Keap1 redox signaling in skeletal muscle of the sedentary old
Safdar, A., deBeer, J., & Tarnopolsky, M. A. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.08.010 · Cited by 158
Aya, V., Flórez, A., Perez, L., & Ramírez, J. D. (2021) · PLOS ONE · doi:10.1371/journal.pone.0247039 · Cited by 158
Rector, R. S., Uptergrove, G. M., Morris, E. M., Borengasser, S. J., Laughlin, M. H., Booth, F. W., Thyfault, J. P., & Ibdah, J. A. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00510.2010 · Cited by 151
Liu, J., Xu, Y., Hu, Y., & Wang, G. (2014) · Metabolism · doi:10.1016/j.metabol.2014.11.009 · Cited by 145 · cited 1×
“In fact, NAFLD is felt to be an FGF-21-resistant state [41,42].”
BackgroundDiniz, T. A., de Lima Junior, E. A., Teixeira, A. A., Biondo, L. A., da Rocha, L. A. F., Valadão, I. C., Silveira, L. S., Cabral-Santos, C., de Souza, C. O., & Rosa Neto, J. C. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118868 · Cited by 144 · cited 3×
“PPAR-γ is heavily involved in glucagon signaling and insulin sensitivity and, thus, is closely related to adiposity-related disorders [94,95].”
BackgroundHarrison, S. A., Abdelmalek, M. F., Neff, G., Gunn, N., Guy, C. D., Alkhouri, N., Bashir, M. R., Freilich, B., Kohli, A., Khazanchi, A., et al. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(22)00017-6 · Cited by 142 · cited 2×
“Multiple isoforms of FGF are involved in the cascade, but FGF-19 and FGF-21 are closely related to fat metabolism [34] and are the signaling pathways for both hormones involved in NAFLD and NASH development and the focus of drug discovery [12,35].”
BackgroundPPARα gene variation and physical performance in Russian athletes
Ahmetov, I. I., Mozhayskaya, I. A., Flavell, D. M., Astratenkova, I. V., Komkova, A. I., Lyubaeva, E. V., Tarakin, P. P., Shenkman, B. S., Vdovina, A. B., Netreba, A. I., et al. (2006) · European Journal of Applied Physiology · doi:10.1007/s00421-006-0154-4 · Cited by 140
Ribeiro, M. O., Bianco, S. D. C., Kaneshige, M., Schultz, J. J., Cheng, S.-Y., Bianco, A. C., & Brent, G. A. (2010) · Endocrinology · doi:10.1210/en.2009-0667 · Cited by 132 · cited 3×
“Importantly, THR-β is intricately linked to other pathways of interest in NAFLD, including PPAR-α, FGF-21 and UCP1 [79,117,118].”
BackgroundCheng, R., Wang, L., Le, S., Yang, Y., Zhao, C., Zhang, X., Yang, X., Xu, T., Xu, L., Wiklund, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29968-0 · Cited by 128
Cheng, S., Ge, J., Zhao, C., Le, S., Yang, Y., Ke, D., Wu, N., Tan, X., Zhang, X., Du, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16159-x · Cited by 127
Zheng, F., & Cai, Y. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-018-0933-z · Cited by 126
Actions and Mode of Actions of FGF19 Subfamily Members
FUKUMOTO, S. (2008) · Endocrine Journal · doi:10.1507/endocrj.kr07e-002 · Cited by 125 · cited 1×
“FGF-19 appears to largely act locally on the hepatocytes, whereas FGF-21 tends to be expressed systemically and, of particular interest, in the skeletal muscle, adipose tissue and in the liver tissue [37,38].”
BackgroundKong, Z., Sun, S., Liu, M., & Shi, Q. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4073618 · Cited by 124 · cited 1×
“Importantly, the relationship between exercise and FGF-21 expression appears to exist across differing intensities, where both moderate and vigorous intensity exercise can change FGF-21 expression [46].”
BackgroundThe Role of Uncoupling Proteins in Diabetes Mellitus
Liu, J., Li, J., Li, W., & Wang, C. (2013) · Journal of Diabetes Research · doi:10.1155/2013/585897 · Cited by 121 · cited 1×
“The dysfunction of these transporters has been correlated with various metabolic disorders, such as obesity and diabetes [76,77], and also NAFLD [78,79].”
BackgroundEffect of moderate - and high-intensity acute exercise on appetite in obese individuals
MARTINS, C., STENSVOLD, D., FINLAYSON, G., HOLST, J., WISLOFF, U., KULSENG, B., MORGAN, L., & KING, N. A. (2015) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000372 · Cited by 119 · cited 1×
“Exercise can impact serum levels of GLP-1, and in fact, exercise can increase GLP-1 levels in healthy individuals and in persons with obesity and suppress appetite [56,57].”
BackgroundMicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease
Fang, Z., Dou, G., & Wang, L. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59588 · Cited by 110
Apró, W., Wang, L., Pontén, M., Blomstrand, E., & Sahlin, K. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00091.2013 · Cited by 109 · cited 1×
“Further, in order to generate additional ATP during exercise, glycogen, which is the main energy substrate used during exercise at higher intensities (typically greater than 70% of VO2max), dissociates from AMPK, leading to AMPK activation (glycogen-bound AMPK is inactive) [18,26,27].”
BackgroundMorville, T., Sahl, R. E., Trammell, S. A. J., Svenningsen, J. S., Gillum, M. P., Helge, J. W., & Clemmensen, C. (2018) · JCI Insight · doi:10.1172/jci.insight.122737 · Cited by 109 · cited 1×
“These potentially confounding factors may explain the conflicting results of FGF-19 downregulation following an acute one-hour bout of aerobic exercise [49] as well as multiple negative studies, which are limited by small sample sizes.”
BackgroundStevanović, J., Beleza, J., Coxito, P. M., Ascensão, A. A. M. R., & Magalhães, J. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.11.015 · Cited by 108
Steinberg, G. R., Watt, M. J., McGee, S. L., Chan, S., Hargreaves, M., Febbraio, M. A., Stapleton, D., & Kemp, B. E. (2006) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h06-003 · Cited by 104
Meissner, M., Lombardo, E., Havinga, R., Tietge, U. J. F., Kuipers, F., & Groen, A. K. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.040 · Cited by 99
The role of FGF21 and its analogs on liver associated diseases
Falamarzi, K., Malekpour, M., Tafti, M. F., Azarpira, N., Behboodi, M., & Zarei, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.967375 · Cited by 94 · cited 1×
“In fact, NAFLD is felt to be an FGF-21-resistant state [41,42].”
BackgroundStine, J. G., DiJoseph, K., Pattison, Z., Harrington, A., Chinchilli, V. M., Schmitz, K. H., & Loomba, R. (2023) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002098 · Cited by 94 · cited 2×
“Importantly, many of these improvements, including the reduction in magnetic resonance imaging (MRI)-measured liver fat, may occur without clinically significant body weight loss [8].”
BackgroundSelf-citationBanitalebi, E., Kazemi, A., Faramarzi, M., Nasiri, S., & Haghighi, M. M. (2019) · Life Sciences · doi:10.1016/j.lfs.2018.11.062 · Cited by 93
Majzoub, A. M., Nayfeh, T., Barnard, A., Munaganuru, N., Dave, S., Singh, S., Murad, M. H., & Loomba, R. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16583 · Cited by 92
Stine, J. G., Long, M. T., Corey, K. E., Sallis, R. E., Allen, A. M., Armstrong, M. J., Conroy, D. E., Cuthbertson, D. J., Duarte-Rojo, A., Hallsworth, K., et al. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000108 · Cited by 89 · cited 2×
“These benefits include an improvement in liver fat, histologic NASH activity, change in body composition, gain in physical fitness, reduction in markers of cardiovascular risk, improvement in health-related quality of life and possibly a reduction in oncologic risk [7].”
BackgroundInfluentialSelf-citationSabag, A., Barr, L., Armour, M., Armstrong, A., Baker, C. J., Twigg, S. M., Chang, D., Hackett, D. A., Keating, S. E., George, J., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab795 · Cited by 88 · cited 1×
“As cardiorespiratory fitness has been shown to improve to a similar degree with both high-intensity interval training (HIIT) and more traditional moderate-intensity continuous training [69], this may, in part, explain why HIIT leads to similar improvements in hepatic steatosis to more moderate-intensity continuous exe…”
BackgroundSelf-citationKlasson, C. L., Sadhir, S., & Pontzer, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270221 · Cited by 84
Impaired Adipogenesis Caused by a Mutated Thyroid Hormone α 1 Receptor
Ying, H., Araki, O., Furuya, F., Kato, Y., & Cheng, S.-Y. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02189-06 · Cited by 83
Cho, J., Lee, I., Kim, D., Koh, Y., Kong, J., Lee, S., & Kang, H. (2014) · Journal of Exercise Nutrition and Biochemistry · doi:10.5717/jenb.2014.18.4.339 · Cited by 83 · cited 1×
“In animal models of NAFLD, multiple studies have shown exercise-induced PPAR-α activation to mediate liver fat reduction [23,95,99,104].”
BackgroundOh, S., Tsujimoto, T., Kim, B., Uchida, F., Suzuki, H., Iizumi, S., Isobe, T., Sakae, T., Tanaka, K., & Shoda, J. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100253 · Cited by 77
Self-citationRegulation of exercise blood flow: Role of free radicals
Trinity, J. D., Broxterman, R. M., & Richardson, R. S. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.01.017 · Cited by 75
Cusi, K., Alkhouri, N., Harrison, S. A., Fouqueray, P., Moller, D. E., Hallakou-Bozec, S., Bolze, S., Grouin, J.-M., Jeannin Megnien, S., Dubourg, J., et al. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00300-9 · Cited by 75 · cited 2×
“For this reason, AMPK remains a drug target of interest, and in fact, the recent Phase 2a STAMP-NAFLD study enrolled 120 patients who were randomized to treatment with PXL770, a direct AMPK activator, or a placebo [16].”
BackgroundSimonet, W. S., & Ness, G. C. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37775-5 · Cited by 71
Impact of Various Exercise Modalities on Hepatic Mitochondrial Function
Fletcher, J. A., Meers, G. M.-E., Linden, M. A., Kearney, M. L., Morris, E. M., Thyfault, J. P., & Rector, R. S. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000223 · Cited by 71 · cited 1×
“Regular exercise has been shown to improve mitochondrial oxidative capacity and increase mitochondrial content, which are related to increases in cardiorespiratory fitness [64,65].”
BackgroundExercising the hepatobiliary‐gut axis. The impact of physical activity performance
Molina‐Molina, E., Baccetto, R., Wang, D. Q. ‐., de Bari, O., Krawczyk, M. J., & Portincasa, P. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12958 · Cited by 70
Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease
Stine, J. G., Soriano, C., Schreibman, I., Rivas, G., Hummer, B., Yoo, E., Schmitz, K., & Sciamanna, C. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06673-w · Cited by 70 · cited 1×
“However, most patients with NAFLD do not meet recommended amounts of weekly physical activity [2], and no one optimal diet has been established, although a Mediterranean-informed diet appears to hold the most promise and is recommended by several leading gastroenterology and hepatology societies [3,4].”
BackgroundSelf-citationPhysical Activity as a Determinant of Fecal Bile Acid Levels
Wertheim, B. C., Martínez, M. E., Ashbeck, E. L., Roe, D. J., Jacobs, E. T., Alberts, D. S., & Thompson, P. A. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-1187 · Cited by 67
Exercise Reduces Inflammation and Oxidative Stress in Obesity-Related Liver Diseases
Oh, S., Tanaka, K., Warabi, E., & Shoda, J. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31829afc33 · Cited by 66
Self-citationVariation in the PPARα gene in Polish rowers
Maciejewska, A., Sawczuk, M., & Cięszczyk, P. (2010) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2010.05.006 · Cited by 66
Sabag, A., Way, K. L., Sultana, R. N., Keating, S. E., Gerofi, J. A., Chuter, V. H., Byrne, N. M., Baker, M. K., George, J., Caterson, I. D., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2523 · Cited by 66 · cited 1×
“In fact, cardiorespiratory fitness is inversely related to hepatic steatosis [66], and improvements in cardiorespiratory fitness are independently associated with improvements in steatosis [67,68].”
BackgroundSelf-citationRegulation of UCP3 by nucleotides is different from regulation of UCP1
Echtay, K. S., Liu, Q., Caskey, T., Winkler, E., Frischmuth, K., Bienengräber, M., & Klingenberg, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00460-3 · Cited by 65
Abdelmalek, M. F., Charles, E. D., Sanyal, A. J., Harrison, S. A., Neuschwander-Tetri, B. A., Goodman, Z., Ehman, R. A., Karsdal, M., Nakajima, A., Du, S., et al. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106335 · Cited by 64 · cited 2×
“Multiple isoforms of FGF are involved in the cascade, but FGF-19 and FGF-21 are closely related to fat metabolism [34] and are the signaling pathways for both hormones involved in NAFLD and NASH development and the focus of drug discovery [12,35].”
BackgroundGonçalves, I. O., Passos, E., Rocha‐Rodrigues, S., Diogo, C. V., Torrella, J. R., Rizo‐Roca, D., Viscor, G., Alves, E. S., Marques‐Aleixo, I., Oliveira, P. J., et al. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.03.012 · Cited by 63
Aristizábal, J. C., Freidenreich, D. J., Volk, B. M., Kupchak, B. R., Sáenz, C., Maresh, C. M., Kraemer, W. J., & Volek, J. S. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.216 · Cited by 59
Hong, J., Park, E., Lee, J., Lee, Y., Rooney, B. V., & Park, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-94944-5 · Cited by 59 · cited 1×
“Animal models have also demonstrated that UCP-2 is modulated by exercise in the vascular endothelium, myocardium, adipose tissue and skeletal muscle [84,88], as is UCP-3 in skeletal muscle [89].”
BackgroundDiscordant hepatic fatty acid oxidation and triglyceride hydrolysis leads to liver disease
Selen, E. S., Choi, J., & Wolfgang, M. J. (2021) · JCI Insight · doi:10.1172/jci.insight.135626 · Cited by 57 · cited 1×
“However, mitochondrial defects, which are related to both physical inactivity and obesity [61], reduce the oxidative capacity of the mitochondria, which results in incomplete β-oxidation and the accumulation of metabolic by-products, such as ceramides and diacylglycerides [62].”
BackgroundAttenuated fibroblast growth factor 21 response to acute aerobic exercise in obese individuals
Slusher, A. L., Whitehurst, M., Zoeller, R. F., Mock, J. T., Maharaj, M., & Huang, C.-J. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.06.002 · Cited by 50
Exercise as Medicine: The Impact of Exercise Training on Nonalcoholic Fatty Liver Disease
Thorp, A., & Stine, J. G. (2020) · Current Hepatology Reports · doi:10.1007/s11901-020-00543-9 · Cited by 50 · cited 1×
“Following years of research, it is widely accepted that regular physical activity and, in particular, exercise training, which is a type of physical activity that is planned, structured, repetitive and with a specific goal in mind [5], leads to many benefits within and outside the liver in patients with NAFLD [6,7].”
BackgroundInfluentialSelf-citationMotahari Rad, M., Bijeh, N., Attarzadeh Hosseini, S. R., & Raouf Saeb, A. (2023) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1829649 · Cited by 49
Thyroid Hormone Receptor-β Agonists in NAFLD Therapy: Possibilities and Challenges
Li, L., Song, Y., Shi, Y., & Sun, L. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad072 · Cited by 49
Amorim, R., Simões, I. C. M., Teixeira, J., Cagide, F., Potes, Y., Soares, P., Carvalho, A., Tavares, L. C., Benfeito, S., Pereira, S. P., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102400 · Cited by 48 · cited 1×
“When expressed in the liver, PPAR-α is responsible for fatty acid catabolism and energy homeostasis [92,93].”
BackgroundLi, D., Ma, J.-M., Li, M., Gao, L., Fan, Y., Zhang, Y., Tao, X., & Yang, J. (2022) · Nutrients · doi:10.3390/nu14153247 · Cited by 47 · cited 2×
“In animal models of NAFLD, multiple studies have shown exercise-induced PPAR-α activation to mediate liver fat reduction [23,95,99,104].”
BackgroundPorflitt-Rodríguez, M., Guzmán-Arriagada, V., Sandoval-Valderrama, R., Tam, C. S., Pavicic, F., Ehrenfeld, P., & Martínez-Huenchullán, S. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155137 · Cited by 46
Mercer, K. E., Maurer, A., Pack, L., Ono‐Moore, K. D., Spray, B. J., Campbell, C., Chandler, C. J., Burnett, D. J., de Souza, E. C. L., Casazza, G. A., et al. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00644.2020 · Cited by 45
Exercise training improves liver steatosis in mice
Alex, S., Boss, A., Heerschap, A., & Kersten, S. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0026-1 · Cited by 44
Brown, E. A., Minnich, A., Sanyal, A. J., Loomba, R. S., Du, S., Schwarz, J., Ehman, R. L., Karsdal, M. A., Leeming, D. J., Cizza, G., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2022.100661 · Cited by 44 · cited 1×
“Both the FALCON and BALANCED trials investigated the efficacy of FGF-21 analogues pegbelfermin and efruxifermin in patients with NASH [13,35,36].”
BackgroundGehrke, N., Biedenbach, J., Huber, Y., Straub, B. K., Galle, P. R., Simon, P., & Schattenberg, J. M. (2019) · Scientific Reports · doi:10.1038/s41598-018-38321-9 · Cited by 43
Qiu, S., Cao, P., Guo, Y. L., Lu, H., & Hu, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.643582 · Cited by 42
Domouzoglou, E. M., Fisher, F. M., Astapova, I., Fox, E. C., Kharitonenkov, A., Flier, J. S., Hollenberg, A. N., & Maratos-Flier, E. (2014) · Endocrinology · doi:10.1210/en.2013-1902 · Cited by 41
Exercise-Induced Autophagy in Fatty Liver Disease
Chun, S. K., Lee, S., Yang, M., Leeuwenburgh, C., & Js, K. (2017) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000116 · Cited by 41
Bae‐Gartz, I., Kasper, P., Großmann, N., Breuer, S., Janoschek, R., Kretschmer, T., Appel, S., Schmitz, L., Vohlen, C., Quaas, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-72022-6 · Cited by 40
Batatinha, H., de Lima, E. A., Teixeira, A. A. D. S., de Souza, C. O., Biondo, L. A., Silveira, L. S., Lira, F. S., & Neto, J. C. R. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25440 · Cited by 39
Danese, E., Salvagno, G. L., Tarperi, C., Negrini, D., Montagnana, M., Festa, L., Sanchis-Gomar, F., Schena, F., & Lippi, G. (2017) · Oncotarget · doi:10.18632/oncotarget.17188 · Cited by 38
Effects of exercise intensity on white adipose tissue browning and its regulatory signals in mice
Tanimura, R., Kobayashi, L., Shirai, T., & Takemasa, T. (2022) · Physiological Reports · doi:10.14814/phy2.15205 · Cited by 38
Aerobic capacity mediates susceptibility for the transition from steatosis to steatohepatitis
Morris, E. M., McCoin, C. S., Allen, J. A., Gastecki, M. L., Koch, L. G., Britton, S. L., Fletcher, J. A., Fu, X., Ding, W., Burgess, S. C., et al. (2017) · The Journal of Physiology · doi:10.1113/jp274281 · Cited by 37 · cited 1×
“Regular exercise has been shown to improve mitochondrial oxidative capacity and increase mitochondrial content, which are related to increases in cardiorespiratory fitness [64,65].”
BackgroundKapravelou, G., Martínez, R., Andrade, A. M., Nebot, E., Camiletti-Moirón, D., Aparicio, V. A., Lopez-Jurado, M., Aranda, P., Arrebola, F., Fernandez-Segura, E., et al. (2015) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2015-0141 · Cited by 35
Ramanjaneya, M., Bensila, M., Bettahi, I., Jerobin, J., Samra, T. A., Aye, M. M., Alkasem, M., Siveen, K. S., Sathyapalan, T., Skarulis, M. C., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.568500 · Cited by 35 · cited 1×
“[50] found that there was no significant change observed in serum FGF-19 in women with polycystic ovarian syndrome following eight weeks of moderateintensity aerobic exercise training.”
BackgroundKim, H. J., Kim, Y. J., & Seong, J. K. (2022) · The Journal of Physiology · doi:10.1113/jp282999 · Cited by 34 · cited 1×
“Animal models have also demonstrated that UCP-2 is modulated by exercise in the vascular endothelium, myocardium, adipose tissue and skeletal muscle [84,88], as is UCP-3 in skeletal muscle [89].”
BackgroundZou, Y., & Qi, Z. (2020) · Mediators of Inflammation · doi:10.1155/2020/6412916 · Cited by 33
Casuso, R. A., Plaza‐Díaz, J., Ruiz‐Ojeda, F. J., Aragón‐Vela, J., Robles-Sánchez, C., Nordsborg, N. B., Hebberecht, M., Salmerón, L. M., & Huertas, J. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185494 · Cited by 32
Takahashi, A., Abe, K., Fujita, M., Hayashi, M., Okai, K., & Ohira, H. (2020) · Medicine · doi:10.1097/md.0000000000020399 · Cited by 32 · cited 1×
“[47] found that after 12 weeks of resistance training in which participants performed push-ups and squats three times a week on non-consecutive days, serum FGF-21 level was significantly reduced, confirming the results seen with aerobic exercise training in animal models of NAFLD.”
ResultLiu, Y., Guo, C., Liu, S., Zhang, S., Mao, Y., & Fang, L. (2021) · Clinical Interventions in Aging · doi:10.2147/cia.s308893 · Cited by 32
Moure, R., Cairó, M., Morón‐Ros, S., Quesada‐López, T., Campderrós, L., Cereijo, R., Hernáez, Á., Villarroya, F., & Giralt, M. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00270.2020 · Cited by 31
Kullman, E. L., Kelly, K. R., Haus, J. M., Fealy, C. E., Scelsi, A. R., Pagadala, M. R., Flask, C. A., McCullough, A. J., & Kirwan, J. P. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00693.2015 · Cited by 30 · cited 1×
“[58] measured the impact of a short-term, one-week high-intensity exercise program and found that while GLP-1 level remained unchanged, exercise instead reversed the GLP-1 resistant state of NAFLD by restoring the normal physiologic response of GLP-1 to glucose stimulation.”
BackgroundSabag, A., Keating, S. E., Way, K. L., Sultana, R. N., Lanting, S. M., Twigg, S. M., & Johnson, N. A. (2021) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-021-00261-9 · Cited by 26 · cited 1×
“In fact, cardiorespiratory fitness is inversely related to hepatic steatosis [66], and improvements in cardiorespiratory fitness are independently associated with improvements in steatosis [67,68].”
BackgroundSelf-citationVidela, L. A., Fernández, V., Vargas, R., Cornejo, P., Tapia, G., Varela, N., Valenzuela, R., Arenas, A., Fernández, J., Hernández‐Rodas, M. C., et al. (2016) · BioFactors · doi:10.1002/biof.1300 · Cited by 25
Hughes, A. J., Dahmus, J., Rivas, G., Hummer, B. L., See, J. R. C., Wright, J., Lamendella, R., Schmitz, K. H., Sciamanna, C., Ruffin, M. T., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.08.063 · Cited by 25
Self-citationNikroo, H., Hosseini, S. R. A., Fathi, M., Sardar, M. A., & Khazaei, M. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113149 · Cited by 25
Exercise Attenuates Ribosomal Protein Six Phosphorylation in Fatty Liver Disease
Stine, J. G., Xu, D., Schmitz, K., Sciamanna, C., & Kimball, S. R. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06226-1 · Cited by 22 · cited 1×
“stream of AMPK, including FGF-21 [31] and also ribosomal protein s6 [32], in patients with NASH, we await a definitive study showing that exercise can directly activate AMPK in this patient population.”
BackgroundSelf-citationExercise ameliorates insulin resistance and improves ASK1‐mediated insulin signalling in obese rats
Zhang, Y., Ye, T., Zhou, P., Li, R., Liu, Z., Xie, J., Hua, T., & Sun, Q. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16994 · Cited by 22
Exercise Training Rapidly Increases Hepatic Insulin Extraction in NAFLD
Hari, A., Fealy, C. E., Axelrod, C. L., Haus, J. M., Flask, C. A., McCullough, A. J., & Kirwan, J. P. (2020) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002273 · Cited by 17 · cited 1×
“This raises the question of the importance of increasing serum GLP-1 level versus ameliorating GLP-1 resistance, building on previous work showing short-term exercise programs to improve hepatic insulin extraction in patients with NAFLD [59].”
ResultStine, J. G., Welles, J. E., Keating, S., Hussaini, Z., Soriano, C., Heinle, J. W., Geyer, N., Chinchilli, V. M., Loomba, R., & Kimball, S. R. (2023) · Nutrients · doi:10.3390/nu15061481 · Cited by 17 · cited 2×
“stream of AMPK, including FGF-21 [31] and also ribosomal protein s6 [32], in patients with NASH, we await a definitive study showing that exercise can directly activate AMPK in this patient population.”
BackgroundSelf-citationHan, T.-R., Yang, W., Tan, Q., Bai, S., Zhong, H., Tai, Y., & Tong, H. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1004911 · Cited by 15 · cited 1×
“Moreover, the gut–liver axis, including the gut microbiome, continues to also be of interest in therapeutic clinical trials in patients with NAFLD and NASH [17].”
BackgroundMuhammad, H. F. L., Sulistyoningrum, D. C., Huriyati, E., Lee, Y. Y., & Muda, W. A. M. W. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520003104 · Cited by 12 · cited 1×
“Moreover, the INDOGENIC cohort study demonstrated that even in healthy individuals, the GG genotype for the UCP-2 G-866A polymorphism changed the physiologic response to energy intake, making these individuals more prone to weight gain and overeating over a two year follow-up period [81].”
BackgroundThe Role of Exercise Intensity on Fatty Liver in Rats
Gu, X., Ma, X., Mo, L., & Wang, Q. (2022) · The Chinese Journal of Physiology · doi:10.4103/0304-4920.365461 · Cited by 11
Dahmus, J., Hummer, B. L., Rivas, G., Schmitz, K. H., Caldwell, S. H., Argo, C. K., Schreibman, I. R., & Stine, J. G. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07809-w · Cited by 10 · cited 1×
“In fact, cardiorespiratory fitness is inversely related to hepatic steatosis [66], and improvements in cardiorespiratory fitness are independently associated with improvements in steatosis [67,68].”
BackgroundSelf-citationDong, C., Lv, Y., Xie, L., Yang, R., Chen, L., Zhang, L., Long, T., Yang, H., Mao, X., Fan, Q., et al. (2020) · Gene · doi:10.1016/j.gene.2020.144497 · Cited by 9
Yin, R., Ma, Y., Zhang, N., Yang, L., & Zhao, D. (2022) · The Chinese Journal of Physiology · doi:10.4103/cjp.cjp_87_21 · Cited by 7
Nishida, Y., Iyadomi, M., Tominaga, H., Taniguchi, H., Higaki, Y., Tanaka, H., Horita, M., Shimanoe, C., Hara, M., & Tanaka, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030703 · Cited by 6
Blond, M. B., Schnurr, T. M., Rosenkilde, M., Quist, J. S., Gram, A. S., Reichkendler, M. H., Auerbach, P., Nordby, P., Skovgaard, L. T., Ribel‐Madsen, R., et al. (2019) · Physiological Genomics · doi:10.1152/physiolgenomics.00101.2018 · Cited by 6
Berahman, H., Elmieh, A., & Chafy, M. R. F. (2021) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2020-0062 · Cited by 6
Liu, Q., Li, H., He, W., Zhao, Q. C., Huang, C., Wang, Q., Zheng, Z., Zhang, X., Shi, X., & Li, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1075986 · Cited by 5
Research works printed but not linked: 1
- Noureddin, 2022, HU6 reduces liver fat in subjects with high BMI NAFLD: Top-line results from a phase 2a trial, Hepatology, 76, S94
Cited by
Keating, S. E., Sabag, A., Hallsworth, K., Hickman, I. J., Macdonald, G. A., Stine, J. G., George, J., & Johnson, N. A. (2023) · Sports Medicine · doi:10.1007/s40279-023-01918-w · Cited by 119
“The mechanisms by which exercise modulates hepatic steatosis have been detailed elsewhere [14, 44–46].”
Self-citationAltered Mitochondrial Function in MASLD: Key Features and Promising Therapeutic Approaches
Radosavljević, T. S., Branković, M., Samardžić, J., Djuretić, J., Vukićević, D., Vučević, D. B., & Jakovljevic, V. L. (2024) · Antioxidants · doi:10.3390/antiox13080906 · Cited by 103
“Exercise has been shown to reduce fat accumulation in the liver by enhancing fatty acid oxidation and inhibiting lipogenesis, primarily through the activation of the AMP-activated protein kinase (AMPK) pathway [62].”
The Role of Exercise in Steatotic Liver Diseases: An Updated Perspective
Razzak, I. A., Fares, A., Stine, J. G., & Trivedi, H. D. (2024) · Liver International · doi:10.1111/liv.16220 · Cited by 61
“In their review, Heinle et al. identify 10 distinct mechanisms or cellular targets through which exercise exerts a therapeutic effect on MASLD [32].”
Self-citationKeating, S. E., Chawla, Y. K., De, A., & George, E. S. (2024) · Hepatology International · doi:10.1007/s12072-024-10663-9 · Cited by 49
“Detailed mechanisms underlying the benefits of exercise on reductions in hepatic steatosis and inflammation are reported elsewhere [17, 57, 69–71]; and summarised in Fig.”
BackgroundSelf-citationAli, H., Shahzil, M., Moond, V., Shahzad, M., Thandavaram, A., Sehar, A., Waseem, H., Siddiqui, T. A., Dahiya, D. S., Patel, P., et al. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14010061 · Cited by 46
“[17,18].”
Background
Metadata
- Authors
- Heinle, J. W., DiJoseph, K., Sabag, A., Oh, S., Kimball, S. R., Keating, S., & Stine, J. G.
- Affiliations
- Pennsylvania State University (US)
- The University of Sydney (AU)
- R Professional University Of Rehabilitation (JP)
- The University of Queensland (AU)
- Corresponding author
- Stine, Jonathan G.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-05-24
- Volume
- 15
- Issue
- 11
- Pages
- 2452
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC10255270
- OpenAlex
- W4378229185
- Cited by
- 26
- References
- 156
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 9 · 2023: 2
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (K23DK131290)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Physiology (medical) › Exercise and Physiological Responses
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
- Keywords
- exercise training, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, fatty acid metabolism, liver inflammation, liver fibrosis, energy expenditure, exercise intensity and volume, drug development
- MeSH terms
- Humans, Liver, Liver Cirrhosis, Exercise, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.